These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FDG PET/CT appearance of multicentric Castleman's disease mimicking lymphoma. Elboga U, Narin Y, Urhan M, Sahin E. Rev Esp Med Nucl Imagen Mol; 2012 Aug; 31(3):142-4. PubMed ID: 22133346 [Abstract] [Full Text] [Related]
3. PET/CT findings in a multicentric form of Castleman's disease. Halac M, Ergul N, Sager S, Demir A, Buyukpinarbasli N, Sonmezoglu K. Hell J Nucl Med; 2007 Aug; 10(3):172-4. PubMed ID: 18084659 [Abstract] [Full Text] [Related]
4. Unicentric and multicentric Castleman's disease. Enomoto K, Nakamichi I, Hamada K, Inoue A, Higuchi I, Sekimoto M, Mizuki M, Hoshida Y, Kubo T, Aozasa K, Hatazawa J. Br J Radiol; 2007 Jan; 80(949):e24-6. PubMed ID: 17267466 [Abstract] [Full Text] [Related]
6. FDG-PET and diffusion-weighted MR imaging appearance in retroperitoneal Castleman's disease: a case report. Oida Y, Shimizu K, Mukai M, Imaizumi T, Nakamura M, Makuuchi H. Clin Imaging; 2008 Jan; 32(2):144-6. PubMed ID: 18313580 [Abstract] [Full Text] [Related]
7. [Fortuitous diagnosis of Castleman's disease by FDG-PET Scan during the follow-up of a renal cancer patient]. Italiano A, Butori C, Verge M, Mouroux J, Thyss A. Rev Med Interne; 2005 Jul; 26(7):597-9. PubMed ID: 15996575 [No Abstract] [Full Text] [Related]
8. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. Lewis PJ, Salama A. J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664 [Abstract] [Full Text] [Related]
13. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation. Iagaru A, Mari C, Sam Gambhir S. Rev Esp Med Nucl; 2007 Oct; 26(1):40-5. PubMed ID: 17286947 [Abstract] [Full Text] [Related]
15. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC. J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337 [Abstract] [Full Text] [Related]
16. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH. Radiographics; 1993 Sep; 13(5):1047-62. PubMed ID: 8210589 [Abstract] [Full Text] [Related]
17. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Newman JS, Francis IR, Kaminski MS, Wahl RL. Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386 [Abstract] [Full Text] [Related]
18. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison]. Bumann D, de Wit M, Beyer W, Beese M, Lübeck M, Bücheler E, Clausen M. Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362 [Abstract] [Full Text] [Related]
19. Is there a role for FDG PET imaging in the management of patients with sarcoidosis? Alavi A, Buchpiguel CA, Loessner A. J Nucl Med; 1994 Oct; 35(10):1650-2. PubMed ID: 7931665 [No Abstract] [Full Text] [Related]